1. Home
  2. IXHL vs GELS Comparison

IXHL vs GELS Comparison

Compare IXHL & GELS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IXHL
  • GELS
  • Stock Information
  • Founded
  • IXHL 2001
  • GELS 2018
  • Country
  • IXHL Australia
  • GELS Australia
  • Employees
  • IXHL N/A
  • GELS N/A
  • Industry
  • IXHL
  • GELS
  • Sector
  • IXHL
  • GELS
  • Exchange
  • IXHL Nasdaq
  • GELS NYSE
  • Market Cap
  • IXHL 13.2M
  • GELS 12.6M
  • IPO Year
  • IXHL N/A
  • GELS 2024
  • Fundamental
  • Price
  • IXHL $0.64
  • GELS $1.01
  • Analyst Decision
  • IXHL
  • GELS
  • Analyst Count
  • IXHL 0
  • GELS 0
  • Target Price
  • IXHL N/A
  • GELS N/A
  • AVG Volume (30 Days)
  • IXHL 61.4K
  • GELS 29.2K
  • Earning Date
  • IXHL 05-14-2025
  • GELS 02-15-2025
  • Dividend Yield
  • IXHL N/A
  • GELS N/A
  • EPS Growth
  • IXHL N/A
  • GELS N/A
  • EPS
  • IXHL N/A
  • GELS N/A
  • Revenue
  • IXHL $98,000.00
  • GELS $95,618.00
  • Revenue This Year
  • IXHL $3,817.06
  • GELS N/A
  • Revenue Next Year
  • IXHL $66.67
  • GELS N/A
  • P/E Ratio
  • IXHL N/A
  • GELS N/A
  • Revenue Growth
  • IXHL N/A
  • GELS N/A
  • 52 Week Low
  • IXHL $0.64
  • GELS $0.90
  • 52 Week High
  • IXHL $3.55
  • GELS $5.50
  • Technical
  • Relative Strength Index (RSI)
  • IXHL 22.16
  • GELS N/A
  • Support Level
  • IXHL $0.73
  • GELS N/A
  • Resistance Level
  • IXHL $1.18
  • GELS N/A
  • Average True Range (ATR)
  • IXHL 0.08
  • GELS 0.00
  • MACD
  • IXHL 0.02
  • GELS 0.00
  • Stochastic Oscillator
  • IXHL 1.74
  • GELS 0.00

About IXHL Incannex Healthcare Inc.

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.

About GELS GELTEQ LIMITED

Gelteq Ltd is a clinical and science-based company that is focused on developing and commercializing white-label gel-based delivery solutions to preserve the simplicity, accessibility and efficacy of oral delivery without the impediments traditionally associated with other oral delivery methods, with prescription drugs, nutraceuticals, pet care, and other products. It is engaged in the development and testing of a gel-based delivery system for humans and pets. Its principal products are edible gels.

Share on Social Networks: